After another positive announcement today the market seemed to react..." Ok...no problem...not excited ...keep it up...we are still awaiting blockbuster stuff ..."
Thats how I read it.
Admedus are building sales, ticking the boxes every announcement against their own milestones and the name is becoming more and more known and respected on the web generally, by brokers, analysts and the wider investment community.
There seems to be a slow but steady build up of credibility and performance that is rstablishing a base for them as a high performing australian biotech on the world stage.
This is ok with me..As a long term holder a gradual, consistent build is reassuring.
Fox
End Of Financial Year Update, page-48
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M | |||
| Open | High | Low | Value | Volume |
| $12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 175 | $11.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.49 | 77 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |